To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Patient Power
Chronic lymphocytic leukemia (CLL) is one of the most common cancers that can be caused by POT1 tumor predisposition syndrome (POT1-TPDS). According to Dipenkumar Modi, M.D., hematologist and medical oncologist, and member of the Bone Marrow and Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams at Karmanos, POT1-TPDS is found in about 5% of patients who have CLL. This is a hereditary mutation, and there is a 50% chance per child that a parent with the mutation can pass it along. Dr. Modi explains a few other cancers POT1-TPDS can cause, some screenings that some patients with the mutation may need, and some advice for patients who know POT1-TPDS runs in their family.
Read the article here.